secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001213900-23-094562
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne receives FDA 510(k) clearance for OneRF Ablation System; plans H1 2024 launch
--------------------------------------------------------------------------------

- FDA 510(k) clearance for OneRF Ablation System to create RF lesions in nervous tissue for functional neurosurgical procedures.
- First FDA-cleared thin-film, sEEG-guided RF system combining recording and ablation with temperature control; third FDA-cleared device.
- Company targets commercial launch in first half of 2024, either directly or through a strategic partner.
- Estimated worldwide brain ablation market at least $100M and growing rapidly, with potential for multifold growth.
- Potential for patients to need only one surgery for both diagnostic and therapeutic procedures, reducing hospital stays and adverse events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023094562/0001213900-23-094562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023094562/ea189752-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-094562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer